SLC2A1 and melanoma: 18F-FDG uptake has been demonstrated as an excellent substrate in measuring the malignant potential for melanoma; when compared to immunohistochemistry, it demonstrated a positive correlation between glucose transporters (GLUT)-1 and GLUT-3, which is the mechanism that 18F-FDG uses to demonstrate malignant tissues in patients with melanoma [5].